Delivering Efficiencies via the Functional Service Provider Model for Investigator Payments

Clinical Trials, Drug Discovery and Development, Life Sciences, Medical Device, Pharmaceutical,
  • November 08, 2017

The number one concern from sites involved in clinical research is the long duration between work completed and accurate payment received. When they are focused on enrolling patients and obtaining that critical clinical data, the last thing they need is financial stress. The site payment process has long been a challenge to the industry and a constant source of inefficiencies.

At Syneos Health, we provide Functional Service Provider (FSP) investigator payments services, which has allowed us to achieve greater efficiencies through the automation of payment processes, industry-leading transparency reporting capabilities, and through integrated data management and site contracting. Unlike specialist vendors, we are able to couple our global payments capabilities with site contracting and data management to create even greater benefits to our customers. We have actively focused on removing the “pain points” related to investigator payments, which is a combination of effort on leveraging the proper technology but more importantly stems from having true global capabilities with experience with all levels of study complexity.

So, what does it take to successfully execute investigator payments, FSP programs and achieve these increased efficiencies? Victoria Moore, Vice President, Investigator Payments, Syneos Health and Shaun Williams, Senior Director, Investigator Payments, Syneos Health, will discuss some of the best practices and crucial elements for executing successful FSP engagements specifically for site payments. Come see what makes Syneos Health a “top choice of sites!”

Speakers

Victoria Moore, FCCA, Vice President, Global Investigator Management Solutions

Victoria joined INC Research in 2003, and during her tenure with the company, has held positions of increasing leadership responsibility. In her current position, she is responsible for the global investigator payments function. Prior to INC, Victoria worked as a public accountant where she gained her ACCA fellowship. Victoria has more than 20 years of experience in the finance sector.

Shaun Williams, Senior Director, Investigator Management Solutions

Shaun Williams joined INC Research in 2015. Prior to this, Mr. Williams was the Vice President of Operations at Clinverse Inc. (now Bioclinica Financial Lifecycle Solutions,) a technology provider to the clinical research industry. Mr. Williams was also previously a Partner at ThinSpring, a company specializing in regulatory compliance software, services, and submissions for structured product labeling (SPL), physician’s labeling rule (PLR), etc. Mr. Williams started his career with Baxter Healthcare in various operations and quality roles throughout the world. Shaun holds a Bachelor of Science in Mechanical Engineering from the United States Military Academy at West Point and is a certified Project Management Professional (PMP).

Who Should Attend?

  • Sites
  • Sponsors

Xtalks Partners

Syneos Health

Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com.

* We expect Syneos Health common shares to trade on the Nasdaq Global Select Market under the new name and new ticker symbol “SYNH” by January 9, 2018. Until then, Syneos Health will continue to be listed under INC Research Holdings, Inc. and the symbol “INCR.”

Related Webinars

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account